These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37204069)

  • 21. Atypical fibroxanthoma and pleomorphic dermal sarcoma: A reappraisal.
    Cesinaro AM; Gallo G; Tramontozzi S; Migaldi M
    J Cutan Pathol; 2021 Feb; 48(2):207-210. PubMed ID: 32583897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleomorphic dermal sarcoma: Clinicopathological features and outcomes from a 5-year tertiary referral centre experience.
    Logan IT; Vroobel KM; le Grange F; Perrett CM
    Cancer Rep (Hoboken); 2022 Nov; 5(11):e1583. PubMed ID: 34766474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytopathology of malignant peripheral nerve sheath tumor: a report of 55 fine-needle aspiration cases.
    Wakely PE; Ali SZ; Bishop JA
    Cancer Cytopathol; 2012 Oct; 120(5):334-41. PubMed ID: 22434579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis.
    Ørholt M; Abebe K; Aaberg F; Rasmussen LE; Daugaard S; Loya AC; Herly M; Vester-Glowinski PV
    Am J Dermatopathol; 2022 Dec; 44(12):913-920. PubMed ID: 36395448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soft tissue aspiration cytopathology.
    Wakely PE; Kneisl JS
    Cancer; 2000 Oct; 90(5):292-8. PubMed ID: 11038426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chordoma: analysis of 47 fine-needle aspiration biopsy, cytologic imprint, and small biopsy specimens.
    Wakely PE; Saoud C; Ali SZ
    J Am Soc Cytopathol; 2023; 12(1):30-40. PubMed ID: 36270910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature.
    Wangsiricharoen S; Ali SZ; Wakely PE
    J Am Soc Cytopathol; 2021; 10(3):310-320. PubMed ID: 33431307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Kuntz T; Grimm A; Hofmann SC; Michalowitz AL; Schaller J; Hellmich M; Assaf C; Oellig F; Kreuter A
    J Dtsch Dermatol Ges; 2024 Apr; 22(4):513-519. PubMed ID: 38483049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients.
    Ørholt M; Abebe K; Rasmussen LE; Aaberg FL; Lindskov LJ; Schmidt G; Wagenblast AL; Petersen MM; Loya AC; Daugaard S; Herly M; Jensen DH; Vester-Glowinski P
    J Am Acad Dermatol; 2023 Dec; 89(6):1177-1184. PubMed ID: 37634740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transthoracic fine-needle aspiration biopsy of pulmonary spindle cell and mesenchymal lesions: a study of 61 cases.
    Hummel P; Cangiarella JF; Cohen JM; Yang G; Waisman J; Chhieng DC
    Cancer; 2001 Jun; 93(3):187-98. PubMed ID: 11391606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classic polymorphous adenocarcinoma: Fine needle aspiration cytopathology of eight cases.
    Wakely PE; Lott-Limbach AA
    Cytopathology; 2021 Nov; 32(6):789-794. PubMed ID: 34346533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas.
    Helbig D; Ihle MA; Pütz K; Tantcheva-Poor I; Mauch C; Büttner R; Quaas A
    Oncotarget; 2016 Apr; 7(16):21763-74. PubMed ID: 26943575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytopathology of myxofibrosarcoma: a study of 66 cases and literature review.
    Wakely PE
    J Am Soc Cytopathol; 2021; 10(3):300-309. PubMed ID: 33041221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytopathology of classic type epithelioid sarcoma: a series of 20 cases and review of the literature.
    Wakely PE
    J Am Soc Cytopathol; 2020; 9(3):126-136. PubMed ID: 32113803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary duct carcinoma: A report of 70 FNA cases and review of the literature.
    Wakely PE
    Cancer Cytopathol; 2022 Aug; 130(8):595-608. PubMed ID: 35255198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.
    Mito JK; Conner JR; Hornick JL; Cibas ES; Qian X
    Cancer Cytopathol; 2018 Mar; 126(3):179-189. PubMed ID: 29385322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
    Miller K; Goodlad JR; Brenn T
    Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma.
    Anders IM; Schimmelpfennig C; Wiedemann K; Löffler D; Kämpf C; Blumert C; Reiche K; Kunz M; Anderegg U; Simon JC; Ziemer M
    J Dtsch Dermatol Ges; 2023 May; 21(5):482-491. PubMed ID: 37035902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.